Roche's TaqMan PCR promises faster results:
This article was originally published in Clinica
Roche says that a first analysis of a prototype Chlamydia test run on its COBAS TaqMan 48 PCR analyser has shown that the instrument can improve overall throughput and enhance overall laboratory operational efficiency. According to the Basel, Switzerland-based company, it was possible to detect 48 processed patient samples in just 2.5 hours using the TaqMan instrument, whereas detecting the same 48 samples on the firm's Cobas Amplicor instrument might take as long as 6.5 hours. The results also showed the Taq-based test to be comparable in sensitivity and specificity to current nucleic acid amplification testing technologies.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.